Literature DB >> 24927609

Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.

Denise C Paranaguá-Vezozzo1, Suzane K Ono1, Mónica V Alvarado-Mora1, Alberto Q Farias1, Marlone Cunha-Silva2, João I D França2, Venancio A F Alves3, Morris Sherman4, Flair José Carrilho1.   

Abstract

BACKGROUND AND AIM: The lack of information about hepatocellular carcinoma (HCC) in Brazil weakens health policy in preventing deaths from the illness. The aim of this study was to establish the cumulative incidence and the risk factors for hepatocellular carcinoma development in patients under a surveillance program.
MATERIAL AND METHODS: 884 patients with compensated cirrhosis were prospectively followed up for at least five years, from August 1998 until August 2008, with at least one annual ultrasonography liver examination and serum alpha fetoprotein (AFP) measurement.
RESULTS: Among 884 patients, 72 (8.1%) developed a tumor with a median follow up of 21.4 months. In the hepatocellular carcinoma group, hepatitis C virus infection was the major etiological factor (65.3%), 56.9% (41/72) were male and the mean average age was 57 ± 10 years. The annual incidence of hepatocellular carcinoma was 2.9%. 79.2% (57/72) of HCCs were detected within Milan Criteria, and the mean survival time was 52.3 months, significantly higher than for those outside Milan, with a mean time of 40.6 months (p = 0.0003).
CONCLUSION: The annual incidence of HCC among this large series of Brazilian cirrhotic patients was around 2.9% with a detection rate of 8.1%, or a cumulative incidence rate over five years of 14.3%. The three variables related to HCC risk were low serum albumin [HR: 0.518 (0.46-0.78)], high AFP > 20 ng/mL [HR: 3.16 (1.86-5.38)], and ethnicity (Brazilian-East Asian descendants vs. other mixed Brazilian ethnicities) [HR: 2.86 (1.48-5.53)].

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24927609

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  28 in total

1.  Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.

Authors:  Zhiliang He; Youjia Yu; Yunhong Nong; Lingyao Du; Cong Liu; Yong Cao; Lang Bai; Hong Tang
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

Review 2.  Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?

Authors:  Christine Pocha; Chencheng Xie
Journal:  Transl Gastroenterol Hepatol       Date:  2019-10-09

Review 3.  Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?

Authors:  Rafael S Pinheiro; Daniel R Waisberg; Lucas S Nacif; Vinicius Rocha-Santos; Rubens M Arantes; Liliana Ducatti; Rodrigo B Martino; Quirino Lai; Wellington Andraus; Luiz A C D'Albuquerque
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-29

Review 4.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.

Authors:  Daniel Q Huang; Hashem B El-Serag; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-21       Impact factor: 46.802

5.  Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C.

Authors:  Nathália Delvaux; Vanessa Duarte da Costa; Maristella Matos da Costa; Livia Melo Villar; Henrique Sérgio Moraes Coelho; Eliane Bordalo Cathalá Esberard; Priscila Pollo Flores; Carlos Eduardo Brandão-Mello; Cristiane Alves Villela-Nogueira; Adilson José de Almeida; Elisabeth Lampe
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-07       Impact factor: 2.743

6.  Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.

Authors:  Aline Lopes Chagas; Luciana Kikuchi; Paulo Herman; Regiane S S M Alencar; Claudia M Tani; Márcio Augusto Diniz; Vincenzo Pugliese; Manoel de Souza Rocha; Luiz Augusto Carneiro D'Albuquerque; Flair Jose Carrilho; Venancio A F Alves
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

7.  Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey.

Authors:  Helma P Cotrim; Claudia P Oliveira; Henrique Sérgio M Coelho; Mario R Alvares-da-Silva; Leticia Nabuco; Edison Roberto Parise; Claúdia Ivantes; Ana Lc Martinelli; João Galizzi-Filho; Flair J Carrilho
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

Review 8.  Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.

Authors:  Rodolfo Castro; Hugo Perazzo; Beatriz Grinsztejn; Valdilea G Veloso; Chris Hyde
Journal:  Int J Hepatol       Date:  2015-11-29

9.  Socioeconomic disparities in access to a hepatocellular carcinoma screening program in Brazil.

Authors:  Izabelle Venturini Signorelli; Patrícia Lofêgo Gonçalves; Luciana Lofêgo Gonçalves; Luiz Sérgio Emery Ferreira; Ana Tereza Parpaiola Mendonça; Gustavo Leite Franklin; Maria da Penha Zago Gomes
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

10.  Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review.

Authors:  Karla Sawada Toda; Luciana Kikuchi; Aline Lopes Chagas; Ryan Yukimatsu Tanigawa; Denise Cerqueira Paranaguá-Vezozzo; Túlio Pfiffer; Manoel de Souza Rocha; Venâncio Avancini Ferreira Alves; Flair José Carrilho
Journal:  J Clin Transl Hepatol       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.